Meridia: The New Anti- Obesity Drug

Meridia: Introduction of new antiobesity medicine In today's society, the hegemonic belief surrounding the weight fades and the fat disappears. More than half of the population in the United States is overweight so meals have spread all over the country. However, large companies have entered the weight loss field of the pharmaceutical industry. After the sudden withdrawal of two anti-obesity drugs from the market in 1997, the pharmaceutical industry has aimed to fill the gap in the market field.

Many people taking Meridia diet pills have various side effects. These medicines are banned in Italy, France, the UK and other European countries. Side effects of this drug are hypertension, arrhythmia, stroke, heart disease, heart failure, hypertension (Center of Disease 115). The next popular medicine that people accept for diet is called orlistat. This is different from most other diet medications as it tries to reduce the amount of fat you absorb while digesting the food. Unless used with a low-fat diet, this has been proved to be an ineffective medicine. Several common side effects experienced by patients are bloating and diarrhea (Center of Disease 115).

Anti-inflammatory drugs are often used to control the effects of inflammation. Glucocorticoids are the most potent of these drugs; however, these drugs may have many adverse side effects like central obesity, hyperglycemia, osteoporosis, and their use is strict It must be managed. Low doses of anti-inflammatory drugs are often used in combination with cytotoxic or immunosuppressive drugs such as methotrexate or azathioprine. Cytotoxic drugs suppress immune responses by killing dividing cells such as activated T cells. However, killing is indiscriminate and other constantly dividing cells and their organs are affected, which can cause toxic side effects. Immunosuppressive drugs such as cyclosporine prevent T cells from reacting properly by inhibiting the signal transduction pathway

Almost all anti-rejection drugs increase the risk of cancer. The immune system walks like a security guard, searching for the wrong cancer cells each day and killing. As you know, they do not refer to these cells as natural killer cells. If you use powerful anti-rejection drugs to eliminate security guards, cancer will spread like madmen. This is what happens in most of these medicines. It is not rapamycin. Interestingly, this drug reduces cancer risk. When it was widely introduced in the 1990's, its mechanism of action was little known. Finally, using the yeast model, targets of rapamycin (TOR) were identified and human counterparts were discovered quickly - hence the name mammalian TOR, now giving an attractive nickname - mTOR